Trastuzumab emtansine with or without pertuzumab versus trastuzumab plus taxane for human epidermal growth factor receptor 2-positive, advanced breast cancer: Primary results from the phase III MARIANNE study

1. Perez, E.A.
2. Barrios, C.
3. Eiermann, W.
4. Toi, M.
5. Im, Y.-H.
6. Conte, P.
7. Martin, M.
8. Pienkowski, T.
9. Pivot, X.
10. Burris, H.
11. Petersen, J.A.
12. Stanze, S.
13. Strasak, A.
14. Patre, M.
15. Ellis, P.

Export

Export

×

MLA

modern-language-association

APA

apa

Chicago

chicago-fullnote-bibliography

Harvard

harvard-cite-them-right

Vancouver

vancouver-author-date

---

RIS BibTex

Export

×

This document cannot be exported because it belongs to another portal.

Full text

lock_openFull text externo

DOI: 10.1200/JCO.2016.67.4887 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals

• 

Data source: Scopus